IDBI Healthcare Fund - IDCW - Direct Plan

  • Previous Nav

  • Net Change on 21-01-2022

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview IDCW | Direct Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The objective of the Scheme is to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors. However there can be no assurance that the investment objective under the scheme will be realized.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
S&P BSE Health Care - TRI -0.43 -4.09 13.80 21.65 11.18 14.77

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
NIPPON INDIA PHARMA FUND - DIRECT Plan - IDCW Option Jan 01, 2013 16.58 25.03 17.82 1.03 5,397.29
SBI Healthcare Opportunities Fund - Direct Plan - Income Distribution cum Capital Withdrawal Option (IDCW) Jan 01, 2013 13.67 23.88 12.47 1.05 1,942.51
UTI Healthcare Fund - Direct Plan - IDCW Jan 01, 2013 14.72 25.19 14.20 1.09 845.91
TATA India Pharma & Health Care Fund Direct Plan - Payout of Income Distribution cum capital withdrawal option Dec 28, 2015 14.73 26.74 16.42 1.06 583.24
TATA India Pharma & Healthcare Fund Direct Plan - Reinvestment of Income Distribution cum capital withdrawal option Dec 28, 2015 14.73 26.74 16.42 1.06 583.24

Fund Holdings as on 31-December-2021

  • Sun Pharmaceutical Industries Ltd.

  • Divi's Laboratories Ltd.

  • Dr. Reddy's Laboratories Ltd.

  • Cipla Ltd.

  • Apollo Hospitals Enterprise Ltd.

  • Aurobindo Pharma Ltd.

  • IPCA Laboratories Ltd.

  • JB Chemicals & Pharmaceuticals Ltd.

  • Gland Pharma Ltd.

  • Torrent Pharmaceuticals Ltd.

  • Lupin Ltd.

  • Alkem Laboratories Ltd.

  • Laurus Labs Ltd.

  • Abbott India Ltd.

  • Syngene International Ltd.

  • Vinati Organics Ltd.

  • Rossari Biotech Ltd.

  • Pfizer Ltd.

  • Cadila Healthcare Ltd.

  • Jubilant Ingrevia Ltd.

  • Metropolis Healthcare Ltd.

  • Tata Steel Ltd.

  • Biocon Ltd.

  • Indoco Remedies Ltd.

  • Aster DM Healthcare Ltd.

  • ICICI Lombard General Insurance Company Ltd.

  • Natco Pharma Ltd.

  • HDFC Life Insurance Company Ltd.

  • TREPS

  • Strides Pharma Science Ltd.

  • Net Receivable / Payable

View More
  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Chemicals

  • Insurance

  • Miscellaneous

  • Steel & Iron Products

View More

About IDBI Healthcare Fund

Scheme Analysis

IDBI Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to IDBI Mutual Fund. It was launched on 28-Feb-2019 and currently has an AUM of ₹74.26 crore. IDBI Healthcare Fund is benchmarked against NIFTY 50 - TRI as primary index and S&P BSE Health Care - TRI as secondary index.

The NAV of IDBI Healthcare Fund ended down ₹-0.27(-1.41%)yesterday to ₹18.84.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Ltd., and

The IDBI Healthcare Fund is managed by Alok Ranjan .

Fund House Contact

5th floor, Mafatlal Centre, Nariman Point Mumbai - 400021

022-6644 2800
022-6644 2802